Blueprint Medicines Corp Stock Price History
| BPMC Stock | USD 88.72 0.25 0.28% |
Below is the normalized historical share price chart for Blueprint Medicines Corp extending back to April 30, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Blueprint Medicines stands at 88.72, as last reported on the 23rd of March, with the highest price reaching 90.25 and the lowest price hitting 86.99 during the day.
If you're considering investing in Blueprint Stock, it is important to understand the factors that can impact its price. At this point, Blueprint Medicines is very steady. Blueprint Medicines Corp secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Blueprint Medicines Corp, which you can use to evaluate the volatility of the firm. Please confirm Blueprint Medicines' Mean Deviation of 2.13, standard deviation of 3.44, and Risk Adjusted Performance of 0.0027 to double-check if the risk estimate we provide is consistent with the expected return of 0.0276%.
At present, Blueprint Medicines' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. . At present, Blueprint Medicines' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 19.27, whereas Price To Sales Ratio is forecasted to decline to 10.24. Blueprint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of April 2015 | 200 Day MA 97.1129 | 50 Day MA 98.9517 | Beta 0.574 |
Blueprint |
Sharpe Ratio = 0.0079
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BPMC |
Estimated Market Risk
| 3.49 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Blueprint Medicines is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Blueprint Medicines by adding Blueprint Medicines to a well-diversified portfolio.
Price Book 18.9836 | Enterprise Value Ebitda 287.1665 | Price Sales 11.1428 | Shares Float 63.2 M | Wall Street Target Price 126.4762 |
Blueprint Medicines Stock Price History Chart
There are several ways to analyze Blueprint Stock price data. The simplest method is using a basic Blueprint candlestick price chart, which shows Blueprint Medicines price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 23, 2025 | 115.63 |
| Lowest Price | March 10, 2025 | 86.69 |
Blueprint Medicines March 23, 2025 Stock Price Synopsis
Various analyses of Blueprint Medicines' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Blueprint Stock. It can be used to describe the percentage change in the price of Blueprint Medicines from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Blueprint Stock.| Blueprint Medicines Price Daily Balance Of Power | 0.08 | |
| Blueprint Medicines Price Action Indicator | 0.23 | |
| Blueprint Medicines Price Rate Of Daily Change | 1.00 |
Blueprint Medicines March 23, 2025 Stock Price Analysis
Blueprint Stock Price History Data
The price series of Blueprint Medicines for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 28.94 with a coefficient of variation of 9.81. The prices are distributed with arithmetic mean of 96.95. The median price for the last 90 days is 92.48.| Open | High | Low | Close | Volume | ||
03/23/2025 | 87.95 | 90.25 | 86.99 | 88.72 | ||
| 03/21/2025 | 87.95 | 90.25 | 86.99 | 88.72 | 1,840,670 | |
| 03/20/2025 | 88.76 | 91.61 | 88.37 | 88.47 | 676,980 | |
| 03/19/2025 | 89.55 | 91.12 | 88.53 | 90.48 | 1,943,865 | |
| 03/18/2025 | 92.34 | 92.34 | 89.42 | 89.59 | 810,114 | |
| 03/17/2025 | 90.88 | 92.38 | 89.39 | 92.14 | 619,979 | |
| 03/14/2025 | 90.44 | 90.84 | 88.00 | 89.58 | 669,910 | |
| 03/13/2025 | 89.95 | 91.02 | 88.25 | 89.84 | 1,807,067 | |
| 03/12/2025 | 87.82 | 90.72 | 86.82 | 90.50 | 995,465 | |
| 03/11/2025 | 87.16 | 88.54 | 85.24 | 87.76 | 618,419 | |
| 03/10/2025 | 85.61 | 87.82 | 84.59 | 86.69 | 632,925 | |
| 03/07/2025 | 89.32 | 90.00 | 86.98 | 87.12 | 908,608 | |
| 03/06/2025 | 88.14 | 89.85 | 86.82 | 88.54 | 576,209 | |
| 03/05/2025 | 89.00 | 90.49 | 87.78 | 89.92 | 1,722,560 | |
| 03/04/2025 | 88.44 | 90.38 | 85.76 | 89.38 | 1,385,852 | |
| 03/03/2025 | 95.28 | 95.55 | 89.12 | 89.75 | 1,514,907 | |
| 02/28/2025 | 90.49 | 96.72 | 90.14 | 96.57 | 1,031,760 | |
| 02/27/2025 | 91.24 | 92.48 | 90.41 | 90.42 | 457,801 | |
| 02/26/2025 | 91.78 | 92.70 | 90.66 | 91.40 | 564,284 | |
| 02/25/2025 | 92.90 | 93.25 | 90.88 | 91.26 | 685,400 | |
| 02/24/2025 | 92.16 | 94.24 | 91.27 | 92.48 | 1,041,183 | |
| 02/21/2025 | 95.60 | 95.60 | 91.71 | 92.25 | 876,268 | |
| 02/20/2025 | 94.24 | 96.78 | 93.12 | 94.35 | 842,019 | |
| 02/19/2025 | 91.67 | 94.49 | 90.84 | 94.07 | 747,431 | |
| 02/18/2025 | 93.73 | 95.10 | 91.61 | 92.48 | 1,266,367 | |
| 02/14/2025 | 96.28 | 96.38 | 92.56 | 93.94 | 1,260,678 | |
| 02/13/2025 | 95.00 | 100.82 | 94.71 | 95.19 | 2,724,491 | |
| 02/12/2025 | 99.33 | 104.92 | 99.08 | 103.56 | 1,147,937 | |
| 02/11/2025 | 103.01 | 104.09 | 100.72 | 101.57 | 975,792 | |
| 02/10/2025 | 105.15 | 105.15 | 100.76 | 104.00 | 1,840,655 | |
| 02/07/2025 | 109.43 | 110.55 | 103.98 | 104.98 | 1,249,125 | |
| 02/06/2025 | 110.37 | 112.00 | 108.84 | 109.62 | 960,415 | |
| 02/05/2025 | 113.55 | 115.77 | 110.17 | 110.37 | 1,169,227 | |
| 02/04/2025 | 110.61 | 114.14 | 110.61 | 113.40 | 886,365 | |
| 02/03/2025 | 109.20 | 112.70 | 109.06 | 111.50 | 757,436 | |
| 01/31/2025 | 114.49 | 116.23 | 112.18 | 112.53 | 578,599 | |
| 01/30/2025 | 115.00 | 116.00 | 112.73 | 114.05 | 1,299,150 | |
| 01/29/2025 | 113.87 | 117.09 | 113.68 | 114.32 | 653,919 | |
| 01/28/2025 | 114.41 | 115.35 | 113.40 | 114.47 | 429,630 | |
| 01/27/2025 | 113.90 | 118.25 | 113.31 | 113.88 | 823,994 | |
| 01/24/2025 | 114.75 | 117.48 | 114.64 | 114.91 | 700,608 | |
| 01/23/2025 | 111.26 | 116.12 | 111.26 | 115.63 | 1,479,677 | |
| 01/22/2025 | 111.54 | 113.57 | 110.80 | 111.08 | 711,609 | |
| 01/21/2025 | 110.24 | 112.52 | 108.16 | 111.96 | 795,122 | |
| 01/17/2025 | 105.87 | 110.28 | 104.73 | 110.05 | 972,266 | |
| 01/16/2025 | 104.88 | 106.49 | 103.67 | 103.95 | 802,696 | |
| 01/15/2025 | 104.38 | 107.88 | 104.38 | 104.89 | 1,114,529 | |
| 01/14/2025 | 103.94 | 105.54 | 101.90 | 102.56 | 1,433,980 | |
| 01/13/2025 | 90.29 | 103.81 | 90.23 | 103.36 | 2,141,976 | |
| 01/10/2025 | 89.11 | 90.56 | 86.72 | 87.43 | 1,299,374 | |
| 01/08/2025 | 93.87 | 94.88 | 90.16 | 90.63 | 927,458 | |
| 01/07/2025 | 90.50 | 95.48 | 90.08 | 94.37 | 655,573 | |
| 01/06/2025 | 88.63 | 91.00 | 88.63 | 89.54 | 653,775 | |
| 01/03/2025 | 87.04 | 89.26 | 86.76 | 88.35 | 555,214 | |
| 01/02/2025 | 88.06 | 89.51 | 86.99 | 87.20 | 329,717 | |
| 12/31/2024 | 87.49 | 87.98 | 85.99 | 87.22 | 363,743 | |
| 12/30/2024 | 88.48 | 88.48 | 85.91 | 86.82 | 621,492 | |
| 12/27/2024 | 90.79 | 91.20 | 87.24 | 89.40 | 657,028 | |
| 12/26/2024 | 90.22 | 91.99 | 89.47 | 91.62 | 267,961 | |
| 12/24/2024 | 90.77 | 90.77 | 89.22 | 90.46 | 113,597 | |
| 12/23/2024 | 89.69 | 90.99 | 88.70 | 90.33 | 335,773 |
About Blueprint Medicines Stock history
Blueprint Medicines investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Blueprint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Blueprint Medicines Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Blueprint Medicines stock prices may prove useful in developing a viable investing in Blueprint Medicines
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 62.9 M | 45.8 M | |
| Net Loss | -501.8 M | -476.7 M |
Blueprint Medicines Quarterly Net Working Capital |
|
Blueprint Medicines Stock Technical Analysis
Blueprint Medicines technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Blueprint Medicines Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Blueprint Medicines' price direction in advance. Along with the technical and fundamental analysis of Blueprint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Blueprint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0027 | |||
| Jensen Alpha | 0.0455 | |||
| Total Risk Alpha | 0.2331 | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Blueprint Stock analysis
When running Blueprint Medicines' price analysis, check to measure Blueprint Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blueprint Medicines is operating at the current time. Most of Blueprint Medicines' value examination focuses on studying past and present price action to predict the probability of Blueprint Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blueprint Medicines' price. Additionally, you may evaluate how the addition of Blueprint Medicines to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |